Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07431931 · ClinicalTrials.gov registry record · NA
Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
A NA study, sponsored by Geisinger Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
NCT07431931 is a NA study that has not yet begun recruiting, run by Geisinger Clinic. The registered enrollment target is 1,200 participants.
The verdict
NCT07431931, a NA study, has not yet begun recruiting, sponsored by Geisinger Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate prospectively the impact of an electronic health record (EHR) alert on primary care providers' (PCP) referral to Nephrology of Geisinger patients with high risk signs (blood and protein in the urine) of glomerulonephritis. This will help quantify the relative effectiveness of EHR alerts on PCPs' referral patterns.
Interventions
- OTHER Electronic Health Record alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2026-11 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07431931
The ClinicalTrials.gov registry entry for NCT07431931 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Health Record alert is the first listed.
NCT07431931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07431931 about?
NCT07431931 is a clinical study titled "Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria". The purpose of the study is to evaluate prospectively the impact of an electronic health record (EHR) alert on primary care providers' (PCP) referral to Nephrology of Geisinger patients with high risk signs (blood and protein in the urine) of glomerulonephritis. This will help quantify the relative ...
What is the current status of trial NCT07431931?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2026-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07431931?
The interventions under investigation include: Electronic Health Record alert (OTHER).
Who is sponsoring clinical trial NCT07431931?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.